Wolverine Trading, LLC Fulcrum Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.18 - $9.74 $44,838 - $137,334	14,100 Added 37.11%	52,100 $185,000
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $14,950 - $23,275	2,500 Added 7.04%	38,000 $235,000
Q1 2024 May 15, 2024	BUY	$6.7 - $12.0 $92,460 - $165,600	13,800 Added 63.59%	35,500 $335,000
Q4 2023 Feb 14, 2024	BUY	$3.18 - $6.86 $19,398 - $41,846	6,100 Added 39.1%	21,700 $146,000
Q3 2023 Nov 15, 2023	BUY	$3.25 - $6.08 $2,275 - $4,256	700 Added 4.7%	15,600 $69,000
Q2 2023 Aug 23, 2023	SELL	$2.26 - $3.8 $6,101 - $10,260	-2,700 Reduced 15.34%	14,900 $49,000
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $49,808 - $246,224	17,600 New	17,600 $50,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $48,720 - $278,400	11,600 New	11,600 $57,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.